
UTEP Student Profile
The University of Texas at El Paso (UTEP) serves a vibrant community of more than 24,000 students. Roughly 84 percent identify as Hispanic, and over half are the first in their families to pursue a college degree.
At 3A Research, we provide sponsors with a trusted platform for conducting high-quality clinical trials. As a multi-location clinical research site network, we are committed to advancing medical research through efficient study conduct, regulatory compliance, and patient-focused care.
As a multi-location clinical research site network in Texas, we conduct sponsor-led clinical trials across our sites with a focus on quality, efficiency, and participant safety. From patient recruitment and enrollment to protocol-driven study visits and accurate data collection, our teams manage each study we conduct to keep the research process running smoothly. Our experience with regulatory compliance and ethical research practices ensures that every study adheres to industry guidelines while maintaining participant safety and data integrity.
Our commitment to innovation and precision allows sponsors to conduct trials with confidence, knowing they have a reliable research partner. By choosing 3A Research, you gain a dedicated team focused on accelerating study timelines, optimizing trial outcomes, and delivering the high-quality results needed for successful drug development.
We have conducted clinical trials across a wide range of therapeutic areas and conditions. Below are some of the key indications we’ve worked on though our experience extends beyond those listed here.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Understanding the diverse populations and communities we serve helps shape our approach to research, education, and community engagement.

The University of Texas at El Paso (UTEP) serves a vibrant community of more than 24,000 students. Roughly 84 percent identify as Hispanic, and over half are the first in their families to pursue a college degree.

Las Cruces—the largest city in Doña Ana County and in all of southern New Mexico—has an estimated population of about 114,892 residents.

Ciudad Juárez, Mexico, is a dynamic border city with an estimated 1.5 million inhabitants.

The city of El Paso, is estimated to have a population of 678,859 with 81.5% identifying as Hispanic or Latino.
Partner with 3A Research for Reliable Clinical Trials
At 3A Research, we are committed to conducting high-quality clinical trials that prioritize patient safety, efficiency, and data integrity. Our research sites are designed to deliver exceptional experiences for both sponsors and participants, ensuring every trial is conducted with precision and care. With a dedicated team and a patient-centered approach, we consistently achieve high enrollment rates and compliance, making us a trusted partner in clinical research.
At 3A Research, we understand that sponsors need an experienced clinical research site partner that delivers efficient, high-quality results. Our team combines hands-on research experience with proven study conduct practices to help keep study timelines on track while maintaining strict regulatory compliance. Through patient-centered recruitment strategies and well-run research sites, we support efficient trial conduct from study startup through study completion. Our commitment to precision and reliability makes us a valuable partner for sponsors seeking dependable clinical trial site conduct.


As a multi-location clinical research site network in Texas, we provide sponsors with access to a diverse patient population, experienced investigators, and well-equipped research facilities. Whether you are developing a new treatment or expanding an existing study, 3A Research offers the strategic advantage needed to bring innovative therapies to market efficiently and effectively.
Accelerate your clinical research with a trusted clinical research site network committed to efficiency, compliance, and high-quality data. Contact 3A Research today to discuss how we can support your next trial and drive meaningful medical advancements.
Let’s advance research together—connect with us now!